Differently, no significant differences were found between the IFN-γ-S-specific response of RA subjects under TNF-α inhibitors, IL-6 inhibitors, or DMARDs compared to that of HCWs (p = 0.172, p = 0.197, and p = 0.022, respectively). The gene discussed is TNF; the disease is rheumatoid arthritis.